| Date | Title | Description |
| 18.02.2025 | Pirche AG Announces Innovation Partnership with Leading Transplant Diagnostics Provider, Devyser AB | Pirche AG today announced its collaboration with leading transplant diagnostics provider, Devyser AB. GRüNWALD, BAVARIA, GERMANY, February 18, 2025 /EINPresswire.com/ -- Pirche AG, a European leader in digital diagnostics serving the transp... |
| 05.12.2023 | Devyser wins tender for non-invasive fetal RHD testing in Wales | Devyser wins tender for non-invasive fetal RHD testing in Wales
Tue, Dec 05, 2023 11:30 CET Report this content
Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in maternal plasma during pregn... |
| 09.11.2023 | Devyser Diagnostics AB publishes quarterly report for July to September 2023 | Devyser Diagnostics AB publishes quarterly report for July to September 2023
Thu, Nov 09, 2023 07:30 CET Report this content
“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further improvement in EBI... |
| 30.10.2023 | Invitation to audiocast for Devyser’s Q3 report 2023 | Invitation to audiocast for Devyser’s Q3 report 2023
Mon, Oct 30, 2023 08:00 CET Report this content
On Thursday November 9, at 09:00 CET, Devyser Diagnostics AB will host an online presentation of its Q3 2023 report (which will have been p... |
| 13.09.2023 | Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research | Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research
Wed, Sep 13, 2023 11:00 CET Report this content
Devyser and Thermo Fisher Scientific have entered into a collaboration agreem... |
| 06.09.2023 | Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding Brazil | Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding Brazil
Wed, Sep 06, 2023 08:00 CET Report this content
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaborat... |
| 23.08.2023 | Devyser Diagnostics AB publishes quarterly report for the period April to June 2023 | Devyser Diagnostics AB publishes quarterly report for the period April to June 2023
Wed, Aug 23, 2023 07:30 CET Report this content
“The second quarter of the year saw an improvement in EBIT compared with recent quarters, continued high gro... |
| 14.08.2023 | Invitation to audiocast for Devyser’s Q2 report 2023 | Invitation to audiocast for Devyser’s Q2 report 2023
Mon, Aug 14, 2023 11:00 CET Report this content
On Wednesday August 23, at 09:00 CET, Devyser Diagnostics AB will host an online presentation of its Q2 2023 report (which will have been p... |
| 17.07.2023 | Devyser’s NGS products for monitoring of kidney and stem cell transplanted patients receive IVDR approvals | Devyser’s NGS products for monitoring of kidney and stem cell transplanted patients receive IVDR approvals
Mon, Jul 17, 2023 14:30 CET Report this content
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from ... |
| 30.06.2023 | Devyser has inaugurated its CLIA-certified laboratory and performed the first patient fetal RhD test | Devyser has inaugurated its CLIA-certified laboratory and performed the first patient fetal RhD test
Fri, Jun 30, 2023 08:00 CET Report this content
Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory w... |
| 29.06.2023 | Devyser Launches Two New Genetic Testing Solutions for Hereditary Cancer | Devyser Launches Two New Genetic Testing Solutions for Hereditary Cancer
Thu, Jun 29, 2023 08:00 CET Report this content
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA PALB2. These kits off... |
| 05.06.2023 | Devyser’s Deputy CEO and founder Ulf Klangby moves to an advisory role | Devyser’s Deputy CEO and founder Ulf Klangby moves to an advisory role
Mon, Jun 05, 2023 08:00 CET Report this content
Devyser’s Deputy CEO and founder Ulf Klangby will leave his position within the company for an advisory role as a consult... |
| 11.05.2023 | Approval of Devyser’s RHD product in Canada | Approval of Devyser’s RHD product in Canada
Thu, May 11, 2023 16:15 CET Report this content
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted regulatory approval in Canada. Devyser already has ... |
| 09.05.2023 | Devyser Diagnostics AB publishes quarterly report for the period January to March 2023 | Devyser Diagnostics AB publishes quarterly report for the period January to March 2023
Tue, May 09, 2023 07:30 CET Report this content
“The first quarter of the year saw continued strong growth, record gross margin and the launching of our ... |
| 08.05.2023 | Devyser’s clinical laboratory receives CLIA certification | Devyser’s clinical laboratory receives CLIA certification
Mon, May 08, 2023 07:00 CET Report this content
Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta, Georgia, has received CLIA certifica... |
| 04.05.2023 | Invitation to audiocast for Devyser’s Q1 report 2023 | Invitation to audiocast for Devyser’s Q1 report 2023
Thu, May 04, 2023 11:00 CET Report this content
On Tuesday May 9, at 09:00 CET, Devyser Diagnostics AB will host an online presentation of its Q1 2023 report (which will have been publish... |
| 24.04.2023 | Devyser enters agreement with Thermo Fisher Scientific for commercialization of Devyser’s post-transplant NGS products | Devyser enters agreement with Thermo Fisher Scientific for commercialization of Devyser’s post-transplant NGS products
Mon, Apr 24, 2023 07:30 CET Report this content
Collaboration and distribution agreement with Thermo Fisher Scientific... |
| 04.04.2023 | Devyser publishes annual report for 2022 | Devyser publishes annual report for 2022
Tue, Apr 04, 2023 15:00 CET Report this content
Devyser´s annual report 2022 has today been published on the company´s website.
The report is available on: https://investors.devyser.com/en/reports-pr... |
| 09.03.2023 | New more sensitive diagnostics protect transplanted kidney | New more sensitive diagnostics protect transplanted kidney
Thu, Mar 09, 2023 08:48 CET Report this content
World Kidney Day 2023
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier, and proper tre... |
| 01.03.2023 | Devyser launches first IVDR-certified product | Devyser launches first IVDR-certified product
Wed, Mar 01, 2023 10:31 CET Report this content
Devyser, the pioneering leader in diagnostic solutions, launches today its first IVDR-certified product. Devyser Compact is a rapid genetic test f... |
| 21.02.2023 | Devyser Diagnostics AB publishes Year-End Report for the period January to December 2022 | Devyser Diagnostics AB publishes Year-End Report for the period January to December 2022
Tue, Feb 21, 2023 07:30 CET Report this content
“Further strong organic growth was reported for the year and quarter. Efforts to build an international... |
| 24.08.2022 | Devyser Diagnostics AB publishes Interim Report for the period, January to June 2022 | Devyser Diagnostics AB publishes Interim Report for the period, January to June 2022
Wed, Aug 24, 2022 08:00 CET Report this content
"Devyser reported another quarter of strong organic growth, which again saw record-breaking sales. The... |
| 17.08.2022 | Invitation to audiocast for Devyser’s Q2 Report 2022 | Invitation to audiocast for Devyser’s Q2 Report 2022
Wed, Aug 17, 2022 11:00 CET Report this content
On Wednesday August 24, at 09.00 CET, Devyser Diagnostics AB will host an online presentation of its Q2 2022 interim report (which will hav... |
| 02.05.2022 | Invitation to audiocast for Devyser’s Q1 Report 2022 | Invitation to audiocast for Devyser’s Q1 Report 2022
Mon, May 02, 2022 11:00 CET Report this content
On Wednesday May 11, at 09.00 CET, Devyser Diagnostics AB will host an online presentation of its Q1 2022 interim report (which will have b... |
| 30.09.2021 | Pia Gideon new Board member of Devyser | Pia Gideon new Board member of Devyser Thu, Sep 30, 2021 16:30 CET
Stockholm, September 30, 2021 – Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announced that Pia Gideon was elected as a new Board member at ... |
